Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
US Market
Holding DNA?
Track your performance easily

Ginkgo Bioworks Holdings (DNA) Cash flow

2,085 Followers

Ginkgo Bioworks Holdings Cash Flow

DNA's free cash flow for Q2 2024 was $-111.23M. For the 2024 fiscal year, DNA's free cash flow was decreased by $-27.40M and operating cash flow was $-84.39M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -305.03M$ -295.50M$ -252.20M$ -253.82M$ -135.83M
Investing Cash Flow
$ -89.01M$ -80.69M$ -67.39M$ -73.26M$ -67.12M
Financing Cash Flow
$ -2.02M$ -3.22M$ 95.34M$ 1.53B$ 90.32M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 3.36B$ 989.58M$ 1.37B$ 1.59B$ 385.88M
Income Tax Paid Supplemental Data
$ -23.00K$ -23.00K$ -981.00K$ -9.40M$ 0.00
Interest Paid Supplemental Data
--$ 92.00K$ 2.37M$ 2.57M
Issuance Of Capital Stock
----$ 91.04M
Issuance Of Debt
$ -1.79M$ -1.29M$ 99.30M-$ 0.00
Repayment Of Debt
$ -1.79M$ -1.29M--$ -748.00K
Free Cash Flow
$ -344.91M$ -331.87M$ -304.47M$ -310.34M$ -193.65M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Ginkgo Bioworks Holdings Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis